Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 8.408.738.635.795.75

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.40 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20268.40
Mar20258.73
Mar20248.63
Mar20235.79
Mar20225.75

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 8.4
-3.78
Mar2025 8.73
1.16
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,164.3 Cr -1.4% -4.7% 7.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.4%

-4.7%

7.7%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses